Pharma Exclusives Pressreleases
Galecto Announces Acquisition of Damora Therapeutics
Monday, November 10, 2025Galecto Inc Galecto today announced the completion of the acquisition of Damora Therapeutics Inc Damora a privately held biotechnology company advancing a pipeline of antibody therapeutics aimed at transforming the treatment of mutant calreticulin mu...
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
Friday, November 07, 2025Eli Lilly and Companytoday announced an agreement with the US government to expand access to its obesity medicines and reduce patient costs The agreement builds on Lillys longstanding commitment to finding solutions with policymakers that improve acc...
Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
Tuesday, November 04, 2025Moderna Inc today announced that the first patient has been dosed in a Phase study of mRNA the Companys investigational mRNAbased Tcell engager TCE for participants with relapsed or refractory multiple myeloma
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
Tuesday, November 04, 2025Merckknown as MSD outside of the United States and Canada today announced that the company through a subsidiary Prometheus BioSciences has reached an agreement with Dr Falk Pharma GmbH Falk to discontinue an existing contract concerning codevelopment...
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
Tuesday, November 04, 2025Merck known as MSD outside of the United States and Canada announced today that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences Blackstone for the development
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis’s ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing
Friday, October 31, 2025Codexis Inc a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Nitto Denko Avecia Inc a leading contract development and manufacturing organization CDMO specializing
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Thursday, October 30, 2025Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine AIBM symposium at the University of North Texas
Celularity and DefEYE, Inc. Partner to Advance Growth of Regenerative Therapies in Eye Care
Thursday, October 30, 2025Celularity Inc a regenerative and cellular medicine company addressing agerelated and degenerative diseases announced today a strategic partnership with DefEYE Inc DefEYE
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients
Wednesday, October 29, 2025Eli Lilly and Companytoday announced it is building the most powerful supercomputer owned and operated by a pharmaceutical company in collaboration with NVIDIA The supercomputer will power an
AbbVie Completes Acquisition of Gilgamesh Pharmaceuticals' Bretisilocin
Saturday, October 18, 2025AbbVieannounced today that it has completed its acquisition of Gilgamesh Pharmaceuticals lead investigational candidate bretisilocin
